Mostrar el registro sencillo del ítem
| dc.contributor.author | Cárceles-Rodríguez, Carlos-Mario | |
| dc.contributor.author | Fernández-Varon, Emilio | |
| dc.contributor.author | Bernal-Alcaraz, Cristina | |
| dc.contributor.author | Cárceles-García, Carlos | |
| dc.contributor.author | Moron-Romero, Rocío | |
| dc.contributor.author | Díaz-Villamarin, Xando | |
| dc.contributor.author | Muñoz-Rascon, Pilar | |
| dc.contributor.author | Serrano-Rodríguez, Juan-Manuel | |
| dc.date.accessioned | 2026-09-17T12:15:43Z | |
| dc.date.available | 2026-09-17T12:15:43Z | |
| dc.date.issued | 2026-06-13 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28144 | |
| dc.description.abstract | The pharmacokinetics (PK) and pharmacokinetic-pharmacodynamic (PK/PD) relationships of cefquinome in small ruminants remain incompletely characterized, particularly for long-acting (LA) formulations. This study evaluated cefquinome disposition after intravenous (IV), subcutaneous (SC) and LA subcutaneous (SC-LA) administration in lactating sheep and goats using nonlinear mixed-effects models (NLMEs) and Monte Carlo (MC) simulations. Cefquinome exhibited low volumes of distribution (0.21-0.31 L/kg), with goats showing higher clearance and shorter terminal half-lives than sheep. The SC-LA formulation reduced the absorption rate constant and increased both the mean absorption time and terminal half-life by 4-6-fold, resulting in sustained systemic exposure over 48 h. PK/PD analysis showed higher PK/PD cut-off values for the LA formulation, with values of 0.125 ?g/mL for the fT > MIC index and 0.25 ?g/mL for the fAUC/MIC index, respectively, whereas IV and SC regimens achieved lower thresholds. MC simulations indicated that only the LA formulation achieved ? 90% probability of target attainment (PTA) values at MICs equivalent to tentative epidemiological cut-off values (TECOFF) for respiratory pathogens. Notably, fAUC/MIC provided a more informative descriptor of efficacy for the LA formulation. These findings highlight the advantage of LA formulations and demonstrate improved performance compared with conventional dosing regimens in sheep and goats. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.rights | Atribución/Reconocimiento 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | * |
| dc.title | Pharmacokinetic/Pharmacodynamic Modelling of Cefquinome in Lactating Sheep and Lactating Goats After Intravenous, Subcutaneous and Long-Acting Administrations | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 42357778 | |
| dc.relation.publisherversion | https://www.mdpi.com/2306-7381/13/6/580 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.3390/vetsci13060580 | |
| dc.journal.title | VETERINARY SCIENCES | |
| dc.identifier.essn | 2306-7381 |